Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GRT-C901 |
| Trade Name | |
| Synonyms | GRTC901|GRT C901 |
| Drug Descriptions |
GRT-C901 is a personalized priming cancer vaccine that encodes patient tumor-specific neoantigens, potentially resulting in increased anti-tumor immune response against neoantigen-expressing tumor cells (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C156925 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + GRT-C901 + GRT-R902 + Ipilimumab | Atezolizumab GRT-C901 GRT-R902 Ipilimumab | 0 | 2 |
| GRT-C901 | GRT-C901 | 0 | 0 |
| GRT-C901 + GRT-R902 + Ipilimumab + Nivolumab | GRT-C901 GRT-R902 Ipilimumab Nivolumab | 0 | 1 |